Compare EVAX & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVAX | FOFO |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | Denmark | Hong Kong |
| Employees | N/A | 14 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 29.7M |
| IPO Year | 2020 | N/A |
| Metric | EVAX | FOFO |
|---|---|---|
| Price | $3.55 | $3.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $11.67 | N/A |
| AVG Volume (30 Days) | 30.5K | ★ 444.9K |
| Earning Date | 05-07-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $328.20 | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.11 | $1.75 |
| 52 Week High | $12.15 | $68.00 |
| Indicator | EVAX | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 39.03 | 54.76 |
| Support Level | $3.32 | $2.32 |
| Resistance Level | $4.65 | $5.96 |
| Average True Range (ATR) | 0.23 | 1.01 |
| MACD | -0.05 | 0.42 |
| Stochastic Oscillator | 25.51 | 32.84 |
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.